Objectives and methods: armA is a novel plasmid-borne 16S rRNA methyltransferase that confers high-level resistance to 4,6-disubstituted deoxystreptamines. Recently, we have isolated from a highlevel broad-spectrum aminoglycoside-resistant Escherichia coli animal isolate a plasmid, pMUR050, that bore the armA gene. In order to elucidate the genetic basis for the spread of armA, we have determined the complete nucleotide sequence of pMUR050.
Introduction
Aminoglycosides are currently used for the treatment of a broad range of life-threatening infections due to both Gram-positive and Gram-negative bacteria. 1 Until recently, resistance to these antibiotics in pathogenic bacteria was restricted to production of aminoglycoside-modifying enzymes, decrease in intracellular antibiotic accumulation and mutation of ribosomal proteins or rRNA. 2 A new type of mechanism, methylation of 16S rRNA, conferred by a single gene, armA, has recently been described in a human Klebsiella pneumoniae isolate. 3 We have identified armA in an Escherichia coli animal isolate, MUR050.
4 This gene conferred high-level resistance to 4,6-substituted deoxystreptamines, including arbekacin, amikacin, kanamycin, tobramycin and gentamicin, and could be transferred to other E. coli by conjugation. Resistance was due to the presence of a single gene, armA, encoding a protein similar to 16S rRNA methylases found in aminoglycoside-producing actinomycetes. The armA gene has also been detected by PCR in additional Enterobacteriaceae from separate hospitals throughout Europe and Japan, showing that high-level aminoglycoside resistance due to armA in Enterobacteriaceae is not a specific finding, but rather a widespread phenomenon that represents a serious clinical challenge. 5 Interestingly, in our E. coli animal isolate, armA was borne by a plasmid, pMUR050, belonging to the IncN incompatibility group, in contrast to human isolates, in which armA has been located in IncL/M plasmids. In this study, we investigated the genetic environment of the armA gene in pMUR050 and show that armA is embedded in a novel transposon composite, making spread between Enterobacteriaceae of human and animal origin likely.
Materials and methods

Bacterial strains
The clinical strain E. coli MUR050 was isolated from a diarrhoeic pig galU galK rpsL (StrR) endA1 nupG] and DH5a [endA1, gyrA96, hsdR17(rk mk+), recA1, relA1, supE44, thi-1, D(lacZYA-argF) U169, f80dl acZDM15, F, lPN25/tetR, Placi q/laci, Spr] were used for cloning purposes and transformed following the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA).
Susceptibility tests
Bacteria were tested using the Etest (AB Biodisk, Solna, Sweden), and interpretation of susceptibility test results was conducted following the recommendations of the manufacturer. For neomycin and apramycin (Izasa, Madrid, Spain), the MICs were determined by microdilution as previously described. 6 DNA sequencing and analysis of pMUR050
Plasmid DNA was extracted from the strain, and re-extracted from an agarose gel to avoid contamination with genomic DNA. 7 The purified plasmid DNA (Qiagen, Inc., Chatworth, CA, USA) was digested with Sau3A (Sigma, St Louis, MO, USA) and the resulting fragments ligated with plasmid pBluescript KS+ DNA (Stratagene, La Jolla, CA, USA). The ligation mixture was transformed into E. coli DH5a and plated on agar containing ampicillin (50 mg/L). The inserts of plasmids from 288 random clones, corresponding to approximately three times the estimated size of pMUR050 (50 kbp) giving a mean cloned fragment of 500 bp, were sequenced in both strands with standard oligonucleotides using an ABI Prism DNA Sequencer apparatus (Perkin-Elmer, Foster City, CA, USA). The DNA sequences were assembled using DNASTAR (Madison, WI, USA).
Results
Resistance conferred by pMUR050 and sequence analysis pMUR050 was transformed into the laboratory strain E. coli INVaF 0 , in which it conferred high-level resistance to 4,6-disubstituted aminoglycosides. This strain was also resistant to other aminoglycosides, sulphonamides and macrolides, showing that resistance determinants other than armA were encoded in pMUR050 (Table 1) .
To determine the genetic basis of this phenomenon, we determined the complete nucleotide sequence of pMUR050 locus by shotgun sequencing. The plasmid has a size of 56 637 bp. Nucleotide sequences were analysed using BLAST. 8 One set of fragments was 99% identical with the conjugative plasmid R46 of the IncN incompatibility group from Salmonella typhimurium. All genes involved in plasmid replication, mobilization and conjugation, such as repA, oriT and the tra family were identified (data not shown), confirming that an R46-like replicon was the carrier of armA. A continuous DNA fragment (GenBank accession number AY522432) with a size of 18 kbp contained all antimicrobial-resistant genes encoded in pMUR050. This fragment included armA and two further genes coding for resistance to aminoglycosides: ant3 00 9 and aph3 0 -I, explaining the broad-spectrum high-level aminoglycoside resistance conferred by pMUR050. sul1, conferring resistance to sulphonamides, the genes coding for the macrolide resistance efflux-pump mefE/mel, characteristic of streptococci, 10 linF and a macrolide phosphotransferase gene, mph, were also identified in the fragment.
armA is located in a complex transposon composite
The structural gene for ArmA was preceded by a putative transposase gene, tnpU, followed by a class one integron formed by intI1-ant3 00 9-qacED1-sul1-orf513. Downstream of armA, the genes coding for another transposase, tnpD, a mefE/mel macrolide efflux pump and a macrolide phosphotransferase gene, mph, were located. All these genes, the armA locus, were flanked by two copies of IS26. IS26 belongs to the IS6 family of insertion sequences. This family is characterized by the fact that it gives rise exclusively to replicon fusions (cointegrates) in which the donor and target replicons are separated by two directly repeated IS copies. Upon cointegration, mediated by either of the two IS26 elements, the IS element is duplicated in a direct repeat. 11 The two IS26 elements at both ends of armA are in direct repeat, forming a putative mobile transposon composite of 15 kbp.
armA transposon composite in other bacterial species
In order to elucidate if this putative mobile genetic element was responsible for the spread of armA, the databases were checked for similar genetic structures. Interestingly, a conjugative plasmid isolated in a Polish hospital from Citrobacter freundii, pCTX-M3, bore the same transposon composite, including armA, with an additional dhfrXII gene and orfF upstream of ant3 00 9 (Figure 1) . Furthermore, the two additional isolates in which armA has been identified to date, a K. pneumoniae in France 3 and an E. coli in Japan (GenBank accession number AB117519), are hospital isolates that showed the same genetic organization flanking the armA gene (Figure 1) . Overall, our results show that armA has spread within a unique transposon composite both by transposition and conjugation, between different species of Enterobacteriaceae involving animal and human isolates.
Discussion
Other authors have recently described two novel 16S rRNA methylases that also confer high-level aminoglycoside resistance in Japanese isolates of Pseudomonas aeruginosa and Serratia marcescens. 12, 13 The genes coding for these methylases, rmtA and rmtB, could also be transferred to other bacteria by conjugation or transformation, indicating that, like armA, rmtA and rmtB can be part of conjugative plasmids. Recently, the description of the genetic environment of rmtA in clinical isolates of P. aeruginosa has given insight into the spread of this methylase within Japan. 14 In the French K. pneumoniae isolate, armA has been located on a mobilizable transposon Tn1548. 15 Thus, armA is already spread by a novel transposon composite in Europe and Japan, and it is likely that it will soon be detected in other regions worldwide. E. coli MUR050 was isolated from a diarrhoeic pig in south-east Spain. 4 The fact that this strain bore armA was already striking, because this gene had only been described in a few human isolates worldwide. In this study, we have further demonstrated that the genetic background for the spread of armA is the same in human and animal strains, indicating that the armA transposon composite will be further detected in Enterobacteriaceae of very diverse origins. This is specially worrisome, as the extended use of sulphonamides or macrolides would select for the presence of the transposon composite, including armA, ant3 00 9, the melF-mef and mph genes. Extended surveillance of both human and animal isolates should be reinforced, if resistance to aminoglycosides is to be delayed.
